Janney Montgomery Scott’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-19,844
Closed -$2.3M – 1945
2018
Q3
$2.3M Buy
19,844
+1,788
+10% +$202K 0.02% 651
2018
Q2
$2.28M Sell
18,056
-5,597
-24% -$681K 0.02% 633
2018
Q1
$2.56M Buy
23,653
+2,138
+10% +$237K 0.03% 566
2017
Q4
$2.36M Buy
21,515
+995
+5% +$99.3K 0.02% 593
2017
Q3
$2.02M Buy
20,520
+8,844
+76% +$857K 0.02% 611
2017
Q2
$1.18M Buy
11,676
+309
+3% +$33.3K 0.01% 801
2017
Q1
$1.31M Buy
11,367
+3,404
+43% +$396K 0.02% 725
2016
Q4
$956K Buy
7,963
+2,968
+59% +$329K 0.01% 793
2016
Q3
$561K Buy
+4,995
New +$575K 0.01% 900
2016
Q1
– Sell
-2,314
Closed -$252K – 1289
2015
Q4
$252K Sell
2,314
-1,633
-41% -$187K 0.01% 1118
2015
Q3
$394K Buy
3,947
+78
+2% +$8.48K 0.01% 943
2015
Q2
$441K Buy
3,869
+721
+23% +$87.4K 0.01% 1252
2015
Q1
$329K Buy
3,148
+97
+3% +$10.3K 0.01% 1694
2014
Q4
$367K Sell
3,051
-635
-17% -$83.4K 0.01% 1537
2014
Q3
$539K Buy
3,686
+1,001
+37% +$155K 0.01% 1221
2014
Q2
$449K Buy
+2,685
New +$478K 0.01% 1305

Other funds holding CLB

Janney Montgomery Scott's CLB Position: Q4 2018 in Review

Janney Montgomery Scott sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 19,844 shares — an estimated $2.3M sold.

Janney Montgomery Scott first reported a position in CLB in Q2 2014 and held it in 16 quarters. The position peaked at $2.56M in Q1 2018. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Janney Montgomery Scott reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Janney Montgomery Scott sold 19,844 Core Laboratories shares in Q4 2018, an estimated $2.3M.
  • Janney Montgomery Scott first reported a position in Core Laboratories in Q2 2014 and held it in 16 quarters.
  • Janney Montgomery Scott's Core Laboratories position peaked at $2.56M in Q1 2018.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Janney Montgomery Scott's 13F filing for Q4 2018, filed 1 Feb 2019.